0 93

Cited 10 times in

Neoadjuvant Chemotherapy and Radiation for Inoperable cacinoma of the Maxillary Antrum: A matched-control study.

DC FieldValueLanguage
dc.contributor.author노재경-
dc.contributor.author이창걸-
dc.contributor.author이창걸-
dc.date.accessioned2019-11-11T05:06:12Z-
dc.date.available2019-11-11T05:06:12Z-
dc.date.issued2000-
dc.identifier.issn0277-3732-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171614-
dc.description.abstractA matched-control study comparing standard radiotherapy versus neoadjuvant chemotherapy and radiation was undertaken to clarify the effects of neoadjuvant systemic chemotherapy for locally advanced squamous cell carcinoma of the maxillary antrum. Thirty-four patients with inoperable maxillary cancer were treated with neoadjuvant chemotherapy and radiotherapy (Group II). Before starting radiotherapy, all patients in Group II received two or three cycles of neoadjuvant chemotherapy consisting of cisplatin and a 5-day continuous infusion of 5-fluorouracil with or without intravenous injection of vinblastine. Radiation doses ranged from 66 Gy to 75 Gy (median, 70 Gy). The response rate, patterns of failure, toxicity, and survival for Group II were compared with those for 34 stage-matched patients treated with radiation alone (Group I). Despite a higher response rate to neoadjuvant chemotherapy, the recurrence rate and patterns of treatment failure were not influenced by the addition of neoadjuvant chemotherapy. In most cases, neoadjuvant chemotherapy did not interfere with subsequent radiotherapy, and radiation-induced late complications occurred equally in both treatment groups. After a median follow-up of 48 months, there was no significant difference in 5-year actuarial survival or disease-free survival between the two treatment groups. Radiation alone for inoperable maxillary cancer was clearly suboptimal for improving local control and survival rate, but neoadjuvant chemotherapy in addition to standard radiotherapy failed to demonstrate any therapeutic advantage over radiation alone.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherLippincott Williams & Wilkins-
dc.relation.isPartOfAmerican Journal of Clinical Oncology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols/therapeutic use*-
dc.subject.MESHCarcinoma, Squamous Cell/drug therapy*-
dc.subject.MESHCarcinoma, Squamous Cell/mortality-
dc.subject.MESHCarcinoma, Squamous Cell/radiotherapy*-
dc.subject.MESHCase-Control Studies-
dc.subject.MESHChemotherapy, Adjuvant-
dc.subject.MESHCisplatin/administration & dosage-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHFemale-
dc.subject.MESHFluorouracil/administration & dosage-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMaxillary Sinus Neoplasms/drug therapy*-
dc.subject.MESHMaxillary Sinus Neoplasms/mortality-
dc.subject.MESHMaxillary Sinus Neoplasms/radiotherapy*-
dc.subject.MESHMiddle Aged-
dc.subject.MESHTreatment Failure-
dc.titleNeoadjuvant Chemotherapy and Radiation for Inoperable cacinoma of the Maxillary Antrum: A matched-control study.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorGwi Eon Kim-
dc.contributor.googleauthorSei Kyung Chang-
dc.contributor.googleauthorSang Wook Lee-
dc.contributor.googleauthorHong Ryull Pyo-
dc.contributor.googleauthorEun Chang Choi-
dc.contributor.googleauthorJae Kyung Roh-
dc.contributor.googleauthorKi Chang Keum-
dc.contributor.googleauthorChang Geol Lee-
dc.contributor.googleauthorChang Ok Suh-
dc.identifier.doi10.1097/00000421-200006000-00020-
dc.contributor.localIdA01290-
dc.contributor.localIdA03240-
dc.contributor.localIdA03240-
dc.contributor.localIdA03240-
dc.contributor.localIdA03240-
dc.relation.journalcodeJ00075-
dc.identifier.eissn1537-453X-
dc.identifier.pmid10857899-
dc.identifier.urlhttps://insights.ovid.com/pubmed?pmid=10857899-
dc.subject.keywordNeoadjuvant chemotherapy-
dc.subject.keywordRadiotherapy-
dc.subject.keywordMaxillary cancer-
dc.subject.keywordinoperable-
dc.contributor.alternativeNameRoh, Jae Kyung-
dc.contributor.affiliatedAuthor노재경-
dc.contributor.affiliatedAuthor이창걸-
dc.contributor.affiliatedAuthor이창걸-
dc.contributor.affiliatedAuthor이창걸-
dc.contributor.affiliatedAuthor이창걸-
dc.citation.volume23-
dc.citation.number3-
dc.citation.startPage301-
dc.citation.endPage308-
dc.identifier.bibliographicCitationAmerican Journal of Clinical Oncology, Vol.23(3) : 301-308, 2000-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.